WebSep 9, 2024 · CureLab Oncology, a clinical-stage, pre-IPO biotech company, is presenting the results of its ongoing ex-US clinical trial at this year’s meeting of the European Society for Medical Oncology (ESMO). WebImmune Modulation in Oncology. Our immuno-oncology platform is designed to harness the power of the immune system to fight cancer. We are developing novel cytokine-based therapies designed to increase visibility of tumor cells to the immune system, increase the tumor-killing potential of CD8+ T and Natural Killer cells, and remove suppressive signals …

CureLab Oncology on LinkedIn: CureLab family is pursuing a …

WebBackground. Here we report the first intermediate analysis of a randomized prospective multi-center clinical study aimed to evaluate safety and efficacy of p62/SQTM1-encoding plasmid applied as an adjuvant to chemotherapy in patients with advanced platinum-resistant ovarian cancer. WebMar 2, 2024 · Ballantyne is the co-founder and former chief scientific officer of Aldevron, a leading manufacturer of plasmids and other biologicals. BOSTON, March 2, 2024 /PRNewswire/ -- The co-founder of Aldevron, Dr. John Ballantyne, has invested $3M in CureLab Oncology, Inc. and CureLab Veterinary.The two sister companies have … greece the country facts for kids

CureLab Oncology Establishes Operations in the Gulf Region - PR …

WebJan 21, 2024 · CureLab Oncology Inc. Jan 21, 2024, 06:00 ET. Share this article. Share this article. BOSTON, July 15, 2024 /PRNewswire/ -- CureLab Veterinary, a newly … WebJul 20, 2024 · CureLab Oncology Inc. is a pre-IPO, clinical-stage immuno-oncology biotech company headquartered in the greater Boston area. CureLab is dedicated to … greece the islands tv series